Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.64 |
| ▸ | TSHR | P16473 | 1/20 | 0.64 |
| ▸ | PDE4B | Q07343 | 12/20 | 0.61 |
| ▸ | PDE3A | Q14432 | 1/20 | 0.57 |
| ▸ | PDE4D | Q08499 | 5/20 | 0.56 |
| ▸ | PDE4A | P27815 | 4/20 | 0.56 |
| ▸ | PDE4C | Q08493 | 3/20 | 0.56 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29808190 | 1.00 | ALDH1A1 (0.64) | ALDH1A1TSHRPDE4BPDE3APDE4D | |
| SCHEMBL7560477 | 1.00 | ALDH1A1 (0.64) | ALDH1A1TSHRPDE4BPDE3APDE4D | |
| SCHEMBL4637156 | 0.98 | ALDH1A1 (0.62) | ALDH1A1TSHRPDE4BPDE3APDE4D | |
| SCHEMBL6883557 | 0.98 | ALDH1A1 (0.66) | ALDH1A1TSHRPDE4BPDE3APDE4D | |
| SCHEMBL2840516 | 0.94 | ALDH1A1 (0.64) | ALDH1A1TSHRPDE4BPDE3APDE4D | |
| SCHEMBL22713946 | 0.94 | ALDH1A1 (0.68) | ALDH1A1TSHRPDE4BPDE3APDE4D | |
| SCHEMBL2847455 | 0.92 | ALDH1A1 (0.62) | ALDH1A1TSHRPDE4BPDE3APDE4D | |
| SCHEMBL27512098 | 0.91 | PDE4B (0.59) | ALDH1A1TSHRPDE4BPDE3APDE4D | |
| SCHEMBL8845986 | 0.90 | PDE4B (0.49) | ALDH1A1TSHRPDE4BPDE3APDE4D | |
| SCHEMBL5905463 | 0.89 | PDE4B (0.48) | ALDH1A1TSHRPDE4BPDE3APDE4D |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 590 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-1946665-B | Preparation method of 3-cyclopentyloxy-4-methoxybenzaldehyde | WYETH CORP | 2011-06-15 | — | — | CN | claimed |
| JP-2007532584-A | — | — | 2007-11-15 | — | — | JP | claimed |
| CN-1946665-A | Preparation method of 3-cyclopentyloxy-4-methoxybenzaldehyde | WYETH CORP (US) | 2007-04-11 | — | — | CN | claimed |
| EP-1751081-A2 | METHOD FOR PREPARING 3-CYCLOPENTYLOXY-4-METHOXYBENZALDEHYDE | Wyeth (US) | 2007-02-14 | — | — | EP | claimed |
| US-7122705-B2 | Method for preparing 3-cyclopentyloxy-4-methoxybenzaldehyde | WYETH (US) | 2006-10-17 | — | — | US | claimed |
| WO-2005100291-A2 | METHOD FOR PREPARING 3-CYCLOPENTYLOXY-4-METHOXYBENZALDEHYDE | WYETH (US) | 2005-10-27 | — | — | WO | claimed |
| US-20050228199-A1 | Method for preparing 3-cyclopentyloxy-4-methoxybenzaldehyde | WYETH (US) | 2005-10-13 | — | — | US | claimed |
| US-5274002-A | 1-Oxy- or -thio-2-cycloalkyloxy-4-carboxyalkylene benzene derivatives | WARNER-LAMBERT COMPANY (US) | 1993-12-28 | — | — | US | claimed |
| JP-7017952-A | — | — | None | — | — | JP | disclosed |
| US-12350283-B2 | Methods and compositions for treating motor neuron diseases | UNIVERSITAT DE VALENCIA-ESTUDI GENERAL (ES) | 2025-07-08 | — | — | US | disclosed |
| CN-120136683-A | Catechol ether compound, pharmaceutical composition and application thereof | 中国药科大学 | 2025-06-13 | — | — | CN | disclosed |
| US-20240415806-A1 | METHODS OF TREATING PRADER-WILLI SYNDROME | LEVO THERAPEUTICS, INC. | 2024-12-19 | — | — | US | disclosed |
| CN-113473993-B | Methods and compositions for treating motor neuron diseases | 巴伦西亚大学 | 2024-06-04 | — | — | CN | disclosed |
| US-11957656-B2 | Methods of treating Prader-Willi syndrome | THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK (US) | 2024-04-16 | — | — | US | disclosed |
| CN-1058771-A | Method for making of oxime carbamate and oxime carbonate ester and uses thereof | AMERICAN HOME PROD (US) | 1992-02-19 | — | — | CN | disclosed |
| EP-0470805-A1 | Oxime-carbamates and oxime-carbonates as bronchodilators and anti-inflammatory agents | AMERICAN HOME PRODUCTS CORPORATION (US) | 1992-02-12 | — | — | EP | disclosed |
| WO-1992000968-A1 | OXAMIDES | SMITHKLINE BEECHAM CORPORATION (US) | 1992-01-23 | — | — | WO | disclosed |
| US-4971959-A | Trisubstituted phenyl analogs having activity for congestive heart failure | WARNER-LAMBERT COMPANY (US) | 1990-11-20 | — | — | US | disclosed |
| US-4308278-A | Anorexigenic 4-[(3,4-dialkoxyphenyl)alkyl]-2-imidazolidinone derivatives | GYOGYSZERKUTATO INTEZET (HU) | 1981-12-29 | — | — | US | disclosed |
| US-4186129-A | CENTRAL NERVOUS SYSTEM DEPRESSANTS, ANTICONVULSANTS | SCHERING AKTIENGESELLSCHAFT (DE) | 1980-01-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050228199-A1 | Method for preparing 3-cyclopentyloxy-4-methoxybenzaldehyde | PAH, HPD, ACMSD | ALDH1A1 941/4885TSHR 4726/4885PDE4B 2673/4885 |
| US-12350283-B2 | Methods and compositions for treating motor neuron diseases | SMN1; SMN2, NNMT, PDE4A | ALDH1A1 237/4885TSHR 4798/4885PDE4B 4/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.